Reticulin‐Free Quantitation of Bone Marrow Fibrosis in MPNs: Utility and Applications
H&E-derived quantitative marrow fibrosis has potential to augment routine practice and clinical trials while supporting the emerging field of spatial multi-omic analysis.
Authors
- Hosuk Ryou (ORCID: https://orcid.org/0000-0001-6450-0117)
- Daniel Royston (ORCID: https://orcid.org/0000-0002-5151-2378)
- Jens Rittscher (ORCID: https://orcid.org/0000-0002-8528-8298)
- Rosalin Cooper (ORCID: https://orcid.org/0000-0002-8548-1178)
- Ka Ho Tam (ORCID: https://orcid.org/0000-0003-4973-098X)
- Emily Thomas (ORCID: https://orcid.org/0000-0002-4563-8695)
- Ruoyu Wang (ORCID: https://orcid.org/0000-0002-0422-6408)
- Luke Harding (ORCID: https://orcid.org/0000-0002-3326-4948)
- Xuezi Hu
- Marta Wojciechowska
Institutions
- University of Oxford (GB)
- Ludwig Cancer Research (GB)
- Oxford BioMedica (United Kingdom) (GB)
- Oxford University Hospitals NHS Trust (GB)
Publication Details
- Journal
- eJHaem
- Published
- 2025-02-27
- DOI
- https://doi.org/10.1002/jha2.70005
- Citations
- 1
- Primary Topic
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.63
Funders
- Ludwig Institute for Cancer Research
- Cancer Research UK
- Jean Shanks Foundation
- Blood Cancer UK
- Engineering and Physical Sciences Research Council